TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. Short Bowel Syndrome Drugs Market
Global Short Bowel Syndrome Drugs Market Research Report 2022

Global Short Bowel Syndrome Drugs Market Research Report 2022

  • Category:Life Sciences
  • Published on : 07 November 2022
  • Pages :96
  • Formats:
  • Report Code:SMR-7480103
OfferClick for best price

Best Price: $2320

Short Bowel Syndrome Drugs Market Size, Share 2022


Market Analysis and Insights: Global Short Bowel Syndrome Drugs Market

The global Short Bowel Syndrome Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Short Bowel Syndrome Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Short Bowel Syndrome Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Short Bowel Syndrome Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Short Bowel Syndrome Drugs market.

Global Short Bowel Syndrome Drugs Scope and Market Size

The research report includes specific segments by region (country), by company, by Type and by Sale Channel. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Segment by Sale Channel

  • Hospital Pharmacies

  • Retail Pharmacies

  • Online Pharmacies

By Region

  • North America

  • U.S.

  • Canada

  • Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Russia

  • Asia-Pacific

  • China

  • Japan

  • South Korea

  • India

  • Australia

  • China Taiwan

  • Indonesia

  • Thailand

  • Malaysia

  • Latin America

  • Mexico

  • Brazil

  • Argentina

  • Middle East & Africa

  • Turkey

  • Saudi Arabia

  • UAE

By Company

  • Emmaus Medical

  • Merck

  • Takeda

  • Ardelyx

  • Naia Pharmaceuticals

  • Nutrinia

  • OxThera

  • GLyPharma Therapeutic

  • Sancilio Pharmaceuticals

  • Zealand Pharma

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Short Bowel Syndrome Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Short Bowel Syndrome Drugs, with price, sales, revenue, and global market share of Short Bowel Syndrome Drugs from 2019 to 2022.

Chapter 3, the Short Bowel Syndrome Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Short Bowel Syndrome Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Short Bowel Syndrome Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Short Bowel Syndrome Drugs.

Chapter 13, 14, and 15, to describe Short Bowel Syndrome Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Short Bowel Syndrome Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Short Bowel Syndrome Drugs Market Research Report 2022
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 96 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Short Bowel Syndrome Drugs Market Overview
1.1 Product Overview and Scope of Short Bowel Syndrome Drugs
1.2 Short Bowel Syndrome Drugs Segment by Type
1.2.1 Global Short Bowel Syndrome Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral Short Bowel Syndrome Drugs
1.2.3 Tablet Short Bowel Syndrome Drugs
1.3 Short Bowel Syndrome Drugs Segment by Sale Channel
1.3.1 Global Short Bowel Syndrome Drugs Sales Comparison by Sale Channel: (2022-2028)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Short Bowel Syndrome Drugs Market Size Estimates and Forecasts
1.4.1 Global Short Bowel Syndrome Drugs Revenue 2017-2028
1.4.2 Global Short Bowel Syndrome Drugs Sales 2017-2028
1.4.3 Short Bowel Syndrome Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Short Bowel Syndrome Drugs Market Competition by Manufacturers
2.1 Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Short Bowel Syndrome Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Short Bowel Syndrome Drugs Manufacturing Sites, Area Served, Product Type
2.5 Short Bowel Syndrome Drugs Market Competitive Situation and Trends
2.5.1 Short Bowel Syndrome Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Short Bowel Syndrome Drugs Players Market Share by Revenue
2.5.3 Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Short Bowel Syndrome Drugs Retrospective Market Scenario by Region
3.1 Global Short Bowel Syndrome Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Short Bowel Syndrome Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Short Bowel Syndrome Drugs Market Facts & Figures by Country
3.3.1 North America Short Bowel Syndrome Drugs Sales by Country
3.3.2 North America Short Bowel Syndrome Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Short Bowel Syndrome Drugs Market Facts & Figures by Country
3.4.1 Europe Short Bowel Syndrome Drugs Sales by Country
3.4.2 Europe Short Bowel Syndrome Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Short Bowel Syndrome Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Region
3.5.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Short Bowel Syndrome Drugs Market Facts & Figures by Country
3.6.1 Latin America Short Bowel Syndrome Drugs Sales by Country
3.6.2 Latin America Short Bowel Syndrome Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Short Bowel Syndrome Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Country
3.7.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Short Bowel Syndrome Drugs Historic Market Analysis by Type
4.1 Global Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022)
4.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Short Bowel Syndrome Drugs Price by Type (2017-2022)
5 Global Short Bowel Syndrome Drugs Historic Market Analysis by Sale Channel
5.1 Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022)
5.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2017-2022)
5.3 Global Short Bowel Syndrome Drugs Price by Sale Channel (2017-2022)
6 Key Companies Profiled
6.1 Emmaus Medical
6.1.1 Emmaus Medical Corporation Information
6.1.2 Emmaus Medical Description and Business Overview
6.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Emmaus Medical Short Bowel Syndrome Drugs Product Portfolio
6.1.5 Emmaus Medical Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Merck Short Bowel Syndrome Drugs Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Takeda
6.3.1 Takeda Corporation Information
6.3.2 Takeda Description and Business Overview
6.3.3 Takeda Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Takeda Short Bowel Syndrome Drugs Product Portfolio
6.3.5 Takeda Recent Developments/Updates
6.4 Ardelyx
6.4.1 Ardelyx Corporation Information
6.4.2 Ardelyx Description and Business Overview
6.4.3 Ardelyx Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ardelyx Short Bowel Syndrome Drugs Product Portfolio
6.4.5 Ardelyx Recent Developments/Updates
6.5 Naia Pharmaceuticals
6.5.1 Naia Pharmaceuticals Corporation Information
6.5.2 Naia Pharmaceuticals Description and Business Overview
6.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio
6.5.5 Naia Pharmaceuticals Recent Developments/Updates
6.6 Nutrinia
6.6.1 Nutrinia Corporation Information
6.6.2 Nutrinia Description and Business Overview
6.6.3 Nutrinia Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Nutrinia Short Bowel Syndrome Drugs Product Portfolio
6.6.5 Nutrinia Recent Developments/Updates
6.7 OxThera
6.6.1 OxThera Corporation Information
6.6.2 OxThera Description and Business Overview
6.6.3 OxThera Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 OxThera Short Bowel Syndrome Drugs Product Portfolio
6.7.5 OxThera Recent Developments/Updates
6.8 GLyPharma Therapeutic
6.8.1 GLyPharma Therapeutic Corporation Information
6.8.2 GLyPharma Therapeutic Description and Business Overview
6.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Portfolio
6.8.5 GLyPharma Therapeutic Recent Developments/Updates
6.9 Sancilio Pharmaceuticals
6.9.1 Sancilio Pharmaceuticals Corporation Information
6.9.2 Sancilio Pharmaceuticals Description and Business Overview
6.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio
6.9.5 Sancilio Pharmaceuticals Recent Developments/Updates
6.10 Zealand Pharma
6.10.1 Zealand Pharma Corporation Information
6.10.2 Zealand Pharma Description and Business Overview
6.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Zealand Pharma Short Bowel Syndrome Drugs Product Portfolio
6.10.5 Zealand Pharma Recent Developments/Updates
7 Short Bowel Syndrome Drugs Manufacturing Cost Analysis
7.1 Short Bowel Syndrome Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Short Bowel Syndrome Drugs
7.4 Short Bowel Syndrome Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Short Bowel Syndrome Drugs Distributors List
8.3 Short Bowel Syndrome Drugs Customers
9 Short Bowel Syndrome Drugs Market Dynamics
9.1 Short Bowel Syndrome Drugs Industry Trends
9.2 Short Bowel Syndrome Drugs Market Drivers
9.3 Short Bowel Syndrome Drugs Market Challenges
9.4 Short Bowel Syndrome Drugs Market Restraints
10 Global Market Forecast
10.1 Short Bowel Syndrome Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Short Bowel Syndrome Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Short Bowel Syndrome Drugs by Type (2023-2028)
10.2 Short Bowel Syndrome Drugs Market Estimates and Projections by Sale Channel
10.2.1 Global Forecasted Sales of Short Bowel Syndrome Drugs by Sale Channel (2023-2028)
10.2.2 Global Forecasted Revenue of Short Bowel Syndrome Drugs by Sale Channel (2023-2028)
10.3 Short Bowel Syndrome Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Short Bowel Syndrome Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Short Bowel Syndrome Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Short Bowel Syndrome Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Short Bowel Syndrome Drugs Sales Growth Rate Comparison by Sale Channel (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Short Bowel Syndrome Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Short Bowel Syndrome Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Short Bowel Syndrome Drugs Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Short Bowel Syndrome Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Short Bowel Syndrome Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Short Bowel Syndrome Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Short Bowel Syndrome Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Short Bowel Syndrome Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Short Bowel Syndrome Drugs Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Short Bowel Syndrome Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Short Bowel Syndrome Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Short Bowel Syndrome Drugs Revenue Share by Type (2017-2022)
Table 43. Global Short Bowel Syndrome Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Sale Channel (2017-2022)
Table 45. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022)
Table 46. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 47. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2017-2022)
Table 48. Global Short Bowel Syndrome Drugs Price by Sale Channel (2017-2022) & (USD/Pcs)
Table 49. Emmaus Medical Corporation Information
Table 50. Emmaus Medical Description and Business Overview
Table 51. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. Emmaus Medical Short Bowel Syndrome Drugs Product
Table 53. Emmaus Medical Recent Developments/Updates
Table 54. Merck Corporation Information
Table 55. Merck Description and Business Overview
Table 56. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. Merck Short Bowel Syndrome Drugs Product
Table 58. Merck Recent Developments/Updates
Table 59. Takeda Corporation Information
Table 60. Takeda Description and Business Overview
Table 61. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. Takeda Short Bowel Syndrome Drugs Product
Table 63. Takeda Recent Developments/Updates
Table 64. Ardelyx Corporation Information
Table 65. Ardelyx Description and Business Overview
Table 66. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Ardelyx Short Bowel Syndrome Drugs Product
Table 68. Ardelyx Recent Developments/Updates
Table 69. Naia Pharmaceuticals Corporation Information
Table 70. Naia Pharmaceuticals Description and Business Overview
Table 71. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product
Table 73. Naia Pharmaceuticals Recent Developments/Updates
Table 74. Nutrinia Corporation Information
Table 75. Nutrinia Description and Business Overview
Table 76. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Nutrinia Short Bowel Syndrome Drugs Product
Table 78. Nutrinia Recent Developments/Updates
Table 79. OxThera Corporation Information
Table 80. OxThera Description and Business Overview
Table 81. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. OxThera Short Bowel Syndrome Drugs Product
Table 83. OxThera Recent Developments/Updates
Table 84. GLyPharma Therapeutic Corporation Information
Table 85. GLyPharma Therapeutic Description and Business Overview
Table 86. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product
Table 88. GLyPharma Therapeutic Recent Developments/Updates
Table 89. Sancilio Pharmaceuticals Corporation Information
Table 90. Sancilio Pharmaceuticals Description and Business Overview
Table 91. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product
Table 93. Sancilio Pharmaceuticals Recent Developments/Updates
Table 94. Zealand Pharma Corporation Information
Table 95. Zealand Pharma Description and Business Overview
Table 96. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. Zealand Pharma Short Bowel Syndrome Drugs Product
Table 98. Zealand Pharma Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Short Bowel Syndrome Drugs Distributors List
Table 102. Short Bowel Syndrome Drugs Customers List
Table 103. Short Bowel Syndrome Drugs Market Trends
Table 104. Short Bowel Syndrome Drugs Market Drivers
Table 105. Short Bowel Syndrome Drugs Market Challenges
Table 106. Short Bowel Syndrome Drugs Market Restraints
Table 107. Global Short Bowel Syndrome Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 108. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Short Bowel Syndrome Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Short Bowel Syndrome Drugs Sales Forecast by Sale Channel (2023-2028) & (K Pcs)
Table 112. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Sale Channel (2023-2028)
Table 113. Global Short Bowel Syndrome Drugs Revenue Forecast by Sale Channel (2023-2028) & (US$ Million)
Table 114. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Sale Channel (2023-2028)
Table 115. Global Short Bowel Syndrome Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 116. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Short Bowel Syndrome Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Short Bowel Syndrome Drugs
Figure 2. Global Short Bowel Syndrome Drugs Market Share by Type in 2021 & 2028
Figure 3. Oral Short Bowel Syndrome Drugs Product Picture
Figure 4. Tablet Short Bowel Syndrome Drugs Product Picture
Figure 5. Global Short Bowel Syndrome Drugs Market Share by Sale Channel in 2021 & 2028
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Global Short Bowel Syndrome Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Short Bowel Syndrome Drugs Market Size (2017-2028) & (US$ Million)
Figure 11. Global Short Bowel Syndrome Drugs Sales (2017-2028) & (K Pcs)
Figure 12. Short Bowel Syndrome Drugs Sales Share by Manufacturers in 2021
Figure 13. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Short Bowel Syndrome Drugs Players: Market Share by Revenue in 2021
Figure 15. Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Short Bowel Syndrome Drugs Sales Market Share by Region in 2021
Figure 18. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2017-2022)
Figure 19. Global Short Bowel Syndrome Drugs Revenue Market Share by Region in 2021
Figure 20. U.S. Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Short Bowel Syndrome Drugs by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Short Bowel Syndrome Drugs
Figure 44. Manufacturing Process Analysis of Short Bowel Syndrome Drugs
Figure 45. Short Bowel Syndrome Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Download
Free Sample
Request
Customization
Check
Discount

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

Delivery Time

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays

  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.

  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer

  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount